965 related articles for article (PubMed ID: 33463388)
41. Decrease in the number of microaneurysms in diabetic macular edema after anti-vascular endothelial growth factor therapy: implications for indocyanine green angiography-guided detection of refractory microaneurysms.
Mori K; Yoshida S; Kobayashi Y; Ishikawa K; Nakao S; Hisatomi T; Haruta M; Isihibashi T; Sonoda KH
Graefes Arch Clin Exp Ophthalmol; 2020 Apr; 258(4):735-741. PubMed ID: 31960130
[TBL] [Abstract][Full Text] [Related]
42. Atrophy of the central neuroretina in patients treated for diabetic macular edema.
Karst SG; Schuster M; Mitsch C; Meyer EL; Kundi M; Scholda C; Schmidt-Erfurth UM
Acta Ophthalmol; 2019 Dec; 97(8):e1054-e1061. PubMed ID: 31228332
[TBL] [Abstract][Full Text] [Related]
43. Association between characteristics of foveal cystoid spaces and short-term responsiveness to ranibizumab for diabetic macular edema.
Murakami T; Suzuma K; Uji A; Yoshitake S; Dodo Y; Fujimoto M; Yoshitake T; Miwa Y; Yoshimura N
Jpn J Ophthalmol; 2018 May; 62(3):292-301. PubMed ID: 29460019
[TBL] [Abstract][Full Text] [Related]
44. Natural history of diabetic macular edema and factors predicting outcomes in sham-treated patients (MEAD study).
Yoon YH; Boyer DS; Maturi RK; Bandello F; Belfort R; Augustin AJ; Li XY; Bai Z; Hashad Y;
Graefes Arch Clin Exp Ophthalmol; 2019 Dec; 257(12):2639-2653. PubMed ID: 31654188
[TBL] [Abstract][Full Text] [Related]
45. OCT Angiography Biomarkers for Predicting Visual Outcomes after Ranibizumab Treatment for Diabetic Macular Edema.
Hsieh YT; Alam MN; Le D; Hsiao CC; Yang CH; Chao DL; Yao X
Ophthalmol Retina; 2019 Oct; 3(10):826-834. PubMed ID: 31227330
[TBL] [Abstract][Full Text] [Related]
46. Quantitative evaluation of hard exudates in diabetic macular edema after short-term intravitreal triamcinolone, dexamethasone implant or bevacizumab injections.
Shin YU; Hong EH; Lim HW; Kang MH; Seong M; Cho H
BMC Ophthalmol; 2017 Oct; 17(1):182. PubMed ID: 28974211
[TBL] [Abstract][Full Text] [Related]
47. Comparison of the efficacy of intravitreal Anti-VEGF versus intravitreal dexamethasone implant in treatment resistant diabetic Macular Edema.
Koc H; Alpay A; Ugurbas SH
BMC Ophthalmol; 2023 Mar; 23(1):97. PubMed ID: 36915060
[TBL] [Abstract][Full Text] [Related]
48. Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema in a Real-World Clinical Setting.
Maggio E; Sartore M; Attanasio M; Maraone G; Guerriero M; Polito A; Pertile G
Am J Ophthalmol; 2018 Nov; 195():209-222. PubMed ID: 30098350
[TBL] [Abstract][Full Text] [Related]
49. Optical Coherence Tomography Angiography of DME and Its Association with Anti-VEGF Treatment Response.
Lee J; Moon BG; Cho AR; Yoon YH
Ophthalmology; 2016 Nov; 123(11):2368-2375. PubMed ID: 27613201
[TBL] [Abstract][Full Text] [Related]
50. OCT outcomes as biomarkers for disease status, visual function, and prognosis in diabetic macular edema.
Velaga SB; Nittala MG; Alagorie AR; Marram J; Hu ZJ; Wang Z; Ciulla TA; Kapik B; Sadda SR; Ip M
Can J Ophthalmol; 2024 Apr; 59(2):109-118. PubMed ID: 36803932
[TBL] [Abstract][Full Text] [Related]
51. Disorganization of Inner Retina and Outer Retinal Morphology in Diabetic Macular Edema.
Das R; Spence G; Hogg RE; Stevenson M; Chakravarthy U
JAMA Ophthalmol; 2018 Feb; 136(2):202-208. PubMed ID: 29327033
[TBL] [Abstract][Full Text] [Related]
52. Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: data from the BEVORDEX randomised clinical trial.
Mehta H; Fraser-Bell S; Yeung A; Campain A; Lim LL; Quin GJ; McAllister IL; Keane PA; Gillies MC
Br J Ophthalmol; 2016 Jul; 100(7):1000-1004. PubMed ID: 26537156
[TBL] [Abstract][Full Text] [Related]
53. Persistent or Recurrent Diabetic Macular Edema After Fluocinolone Acetonide 0.19 mg Implant: Risk Factors and Management.
Cicinelli MV; Rabiolo A; Zollet P; Capone L; Lattanzio R; Bandello F
Am J Ophthalmol; 2020 Jul; 215():14-24. PubMed ID: 32209341
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of the New "SAVE" Protocol in Diabetic Macular Edema Over the Course of Anti-VEGF Treatment.
Reznicek L; Bolz M; Garip A; Kampik A; Kernt M; Mayer WJ
Curr Eye Res; 2016 Aug; 41(8):1082-1086. PubMed ID: 26580417
[TBL] [Abstract][Full Text] [Related]
55. Aflibercept vs. dexamethasone implant for recalcitrant diabetic macular edema in pseudophakic eyes - 1-year outcomes from a quazi-randomized study in India.
Chakraborty D; Mondal S; Sengupta S; Maiti A; Boral S; Das A; Sinha TK; Nandi K
Indian J Ophthalmol; 2024 Jul; 72(7):1001-1006. PubMed ID: 38622856
[TBL] [Abstract][Full Text] [Related]
56. Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema.
Sheth S; Rush R; Natarajan S; Gillies M
Clin Exp Ophthalmol; 2011; 39(7):673-81. PubMed ID: 22452685
[TBL] [Abstract][Full Text] [Related]
57. Changes in choroidal thickness after anti-vascular endothelial growth factor treatment of diabetic macular edema, real-life data, 2-year results.
Savur F; Kaldırım H; Atalay K; Korkmaz Ş
Cutan Ocul Toxicol; 2021 Dec; 40(4):326-331. PubMed ID: 34275395
[TBL] [Abstract][Full Text] [Related]
58. Intravitreal dexamethasone implant in patients with persistent diabetic macular edema.
Zucchiatti I; Lattanzio R; Querques G; Querques L; Del Turco C; Cascavilla ML; Bandello F
Ophthalmologica; 2012; 228(2):117-22. PubMed ID: 22310491
[TBL] [Abstract][Full Text] [Related]
59. Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema.
Busch C; Zur D; Fraser-Bell S; Laíns I; Santos AR; Lupidi M; Cagini C; Gabrielle PH; Couturier A; Mané-Tauty V; Giancipoli E; Ricci GD; Cebeci Z; Rodríguez-Valdés PJ; Chaikitmongkol V; Amphornphruet A; Hindi I; Agrawal K; Chhablani J; Loewenstein A; Iglicki M; Rehak M;
Acta Diabetol; 2018 Aug; 55(8):789-796. PubMed ID: 29730822
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of the effect of combined intravitreal ranibizumab injection and sub-tenon steroid injection in the treatment of resistant diabetic macular edema.
Eriş E; Perente I; Vural E; Vural A; Seymen Z; Celebi ARC; Erdogan G; Ozkaya A; Artunay O
Int Ophthalmol; 2019 Jul; 39(7):1575-1580. PubMed ID: 29943100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
